These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 34683883)
21. Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation. Xing Y; Zhu L; Zhang K; Li T; Huang S Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):308-316. PubMed ID: 33739906 [TBL] [Abstract][Full Text] [Related]
22. Optimization and Characterization of Low-Molecular-Weight Chitosan-Coated Baicalin mPEG-PLGA Nanoparticles for the Treatment of Cataract. Li N; Zhao Z; Ma H; Liu Y; Nwafor EO; Zhu S; Jia L; Pang X; Han Z; Tian B; Pan H; Liu Z; Pan W Mol Pharm; 2022 Nov; 19(11):3831-3845. PubMed ID: 36067066 [TBL] [Abstract][Full Text] [Related]
23. [Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles]. Pan Y; Li YJ; Gao P; Ding PT; Xu H; Zheng JM Yao Xue Xue Bao; 2003 Jun; 38(6):467-70. PubMed ID: 14513811 [TBL] [Abstract][Full Text] [Related]
24. Bioavailability of Orally Delivered Alpha-Tocopherol by Poly(Lactic-Co-Glycolic) Acid (PLGA) Nanoparticles and Chitosan Covered PLGA Nanoparticles in F344 Rats. Simon LC; Stout RW; Sabliov C Nanobiomedicine (Rij); 2016; 3():8. PubMed ID: 29942383 [TBL] [Abstract][Full Text] [Related]
25. Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium. Arafa MG; Girgis GNS; El-Dahan MS Int J Nanomedicine; 2020; 15():1335-1347. PubMed ID: 32184589 [TBL] [Abstract][Full Text] [Related]
26. Poly(Lactic-co-Glycolic Acid Nanoparticles Loaded with Docetaxel and Coated with Chitosan, Carboxymethyl Chitosan, or Glycol Chitosan. Al-Nemrawi NK; Abu Dayah A; Darweesh R Curr Pharm Biotechnol; 2024 Oct; ():. PubMed ID: 39377383 [TBL] [Abstract][Full Text] [Related]
27. Preparation and hydrolytic erosion of differently structured PLGA nanoparticles with chitosan modification. Ma FK; Li J; Kong M; Liu Y; An Y; Chen XG Int J Biol Macromol; 2013 Mar; 54():174-9. PubMed ID: 23262384 [TBL] [Abstract][Full Text] [Related]
28. Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery. Lu B; Lv X; Le Y Polymers (Basel); 2019 Feb; 11(2):. PubMed ID: 30960288 [TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
30. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency. Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112 [TBL] [Abstract][Full Text] [Related]
31. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
32. Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles. Alassaif FR; Alassaif ER; Kaushik AK; Dhanapal J Recent Pat Nanotechnol; 2023; 17(1):74-82. PubMed ID: 35021983 [TBL] [Abstract][Full Text] [Related]
33. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel. Abouelmagd SA; Ku YJ; Yeo Y J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and Evaluation of BSA-Loaded PLGA-Chitosan Composite Nanoparticles for the Protein-Based Drug Delivery System. Gaur M; Maurya S; Akhtar MS; Yadav AB ACS Omega; 2023 May; 8(21):18751-18759. PubMed ID: 37273604 [TBL] [Abstract][Full Text] [Related]
35. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
36. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873 [TBL] [Abstract][Full Text] [Related]
38. Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines. Alshetaili AS Saudi J Biol Sci; 2021 Sep; 28(9):5065-5073. PubMed ID: 34466084 [TBL] [Abstract][Full Text] [Related]
39. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines. Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665 [TBL] [Abstract][Full Text] [Related]
40. Chitosan Oleate Salt as an Amphiphilic Polymer for the Surface Modification of Poly-Lactic-Glycolic Acid (PLGA) Nanoparticles. Preliminary Studies of Mucoadhesion and Cell Interaction Properties. Miele D; Rossi S; Sandri G; Vigani B; Sorrenti M; Giunchedi P; Ferrari F; Bonferoni MC Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30445668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]